Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis. [electronic resource]
- Scientific reports 05 2019
- 7086 p. digital
Publication Type: Journal Article; Multicenter Study